株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

医薬品分析試験アウトソーシング市場の分析:サービス(生物学的分析試験、試験方法の開発および検証、安全性テスト)、地域別

Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical, Stability, Method Development & Validation), By Region, And Segment Forecasts, 2020 - 2027

発行 Grand View Research, Inc. 商品コード 447160
出版日 ページ情報 英文 92 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.09円で換算しております。
医薬品分析試験アウトソーシング市場の分析:サービス(生物学的分析試験、試験方法の開発および検証、安全性テスト)、地域別 Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical, Stability, Method Development & Validation), By Region, And Segment Forecasts, 2020 - 2027
出版日: 2020年02月13日 ページ情報: 英文 92 Pages
概要

当レポートでは、医薬品分析試験アウトソーシング市場について分析し、基本的な市場構造や、主な市場促進・抑制要因、サービス、地域別の市場動向、収益予測、主要企業のプロファイル、事業戦略などについて調査・考察しております。

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 医薬品分析試験アウトソーシング市場:市場の動向

  • 市場区分と範囲
  • 市場促進要因の分析
  • 浸透・成長見通しのマッピング
  • SWOT分析
  • ファイブフォース分析

第4章 医薬品分析試験アウトソーシング市場:サービス別動向

  • 医薬品分析試験アウトソーシング市場:サービス別市場シェア
  • 市場規模・見通し・動向分析

第5章 医薬品分析試験アウトソーシング市場:地域別動向

  • 医薬品分析試験アウトソーシング市場:地域別市場シェア 2015、2025年
  • 北米(米国、カナダ)
  • 欧州(英国、ドイツ)
  • アジア太平洋(日本、中国)
  • ラテンアメリカ(ブラジル、メキシコ)
  • 中東・アフリカ(南アメリカ)

第6章 競合情勢

  • 戦略の枠組み
  • 企業プロファイル
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global pharmaceutical analytical testing outsourcing market, by region, 2016 - 2027 (USD Million)
  • Table 4 Global pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 5 North America pharmaceutical analytical testing outsourcing market, by country, 2016 - 2027 (USD Million)
  • Table 6 North America pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 7 U.S. pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 8 Canada pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 9 Europe pharmaceutical analytical testing outsourcing market, by country, 2016 - 2027 (USD Million)
  • Table 10 Europe pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 11 U.K. pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 12 Germany pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 13 France pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 14 Italy pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 15 Spain pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 16 Russia pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 17 Turkey pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 18 Netherlands pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 19 Switzerland pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 20 Sweden pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 21 Asia Pacific pharmaceutical analytical testing outsourcing market, by country, 2016 - 2027 (USD Million)
  • Table 22 Asia Pacific pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 23 Japan pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 24 China pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 25 India pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 26 Australia pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 27 South Korea pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 28 Indonesia pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 29 Malaysia pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 30 Singapore pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 31 Thailand pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 32 Taiwan pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 33 Latin America pharmaceutical analytical testing outsourcing market, by country, 2016 - 2027 (USD Million)
  • Table 34 Latin America pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 35 Brazil pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 36 Mexico pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 37 Argentina pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 38 Colombia pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 39 Chile pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 40 MEA pharmaceutical analytical testing outsourcing market, by country, 2016 - 2027 (USD Million)
  • Table 41 MEA pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 42 South Africa pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 43 Saudi Arabia pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 44 UAE pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 45 Egypt pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)
  • Table 46 Israel pharmaceutical analytical testing outsourcing market, by service, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Pharmaceutical analytical testing outsourcing market: Market snapshot
  • Fig. 9 Pharmaceutical analytical testing outsourcing market: Market segmentation
  • Fig. 10 Pharmaceutical analytical testing outsourcing market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Pharmaceutical analytical testing outsourcing market driver impact
  • Fig. 14 Pharmaceutical analytical testing outsourcing market restraint impact
  • Fig. 15 Pharmaceutical analytical testing outsourcing market Porter's Five Forces analysis
  • Fig. 16 Pharmaceutical analytical testing outsourcing market PESTEL analysis
  • Fig. 17 Pharmaceutical analytical testing outsourcing market segment dashboard
  • Fig. 18 Pharmaceutical analytical testing outsourcing market: Service Movement Analysis
  • Fig. 19 Bioanalytical testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 20 Clinical market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 21 Non-clinical market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 22 Method development & validation market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 23 Extractable & leachable market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 24 Impurity method market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 25 Technical consulting market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 26 Others market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 27 Stability testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 28 Drug substance market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 29 Stability indicating method validation market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 30 Accelerated stability testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 31 Photostability testing market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 32 Others market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 33 Other testing services market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 34 Pharmaceutical analytical testing outsourcing market: Regional movement analysis
  • Fig. 35 Pharmaceutical analytical testing outsourcing: Regional outlook and key takeaways
  • Fig. 36 North America market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 37 U.S. market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 38 Canada market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 39 Europe market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 40 U.K. market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 41 Germany market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 42 France market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 43 Italy market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 44 Spain market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 45 Russia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 46 Turkey market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 47 Netherlands market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 48 Switzerland market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 49 Sweden market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 50 Asia Pacific market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 51 Japan market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 52 China market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 53 India market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 54 Australia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 55 South Korea market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 56 Indonesia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 57 Malaysia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 58 Singapore market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 59 Thailand market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 60 Taiwan market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 61 Latin America market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 62 Brazil market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 63 Mexico market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 64 Argentina market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 65 Colombia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 66 Chile market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 67 Middle East and Africa. market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 68 South Africa market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 69 Saudi Arabia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 70 UAE market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 71 Egypt market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 72 Israel market estimates and forecast, 2016 - 2027 (USD Million)
目次
Product Code: GVR-1-68038-365-2

The global pharmaceutical analytical testing outsourcing market size is expected to reach USD 11.4 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 8.3% over the forecast period. Increasing pipelines for biological candidates, rising demand for additional analytical details on drugs, and process development by regulatory agencies are boosting the market growth.

Analytical testing helps in providing real-time product quality control along with optimizing and monitoring processes, characterizing biosimilars and biologics, and improving productivity. One of the main reasons for outsourcing analytical testing services is to benefit from skilled and experienced professionals, as well as to access expensive analytical equipment which are not available in-house.

Increased development of biologics is also creating a demand for analytical testing services. In the last three decades, biologics have taken the center stage in the discovery and development of drugs. Moreover, there is a high demand to define higher-order biological structures. The need for better product characterization, along with comparability studies, especially for biosimilars, further leads to drug companies outsourcing these services.

A patent cliff, particularly for small molecules in the pharmaceutical industry leads to a decline in revenue, thereby affecting profits. Over the next few years, several best-selling biologics would come toward the end of patent life, such as Humira. Drug innovators are therefore under constant pressure to bring new products through the pipeline at a faster rate. Developing advanced analytical testing to assess and monitor the quality attributes of these products requires a broader set of equipment and expertise, which is beyond the internal capacity of pharma companies. This would subsequently lead to increased instances of outsourcing pharmaceutical analytical testing services.

Further key findings from the report suggest:

  • The outsourcing of clinical bioanalytical testing services emerged as the largest segment in 2019 with a share of around 79% owing to the increasing number of clinical trials
  • The extractable and leachable services segment is expected to witness a significant growth rate owing to an increasing number of vendors offering these services at competitive prices
  • North America dominated the global market with a share of 54.2% in 2019 as the region is one of the top manufacturing hubs of highly reliable, complex, and high-end pharmaceuticals

Some of the players operating in the pharmaceutical analytical testing outsourcing market are Toxikon, Inc.; Intertek Group PLC; SGS SA; Eurofins Scientific; Boston Analytical; Pace Analytical Services, LLC; West Pharmaceutical Services, Inc.; Intertek Group Plc; Pharmaceutical Product Development, LLC; WuXi AppTec, Inc.; and Charles River Laboratories International, Inc.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Service
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1: Understanding the market dynamics
    • 1.9.2. Objective 2: Understanding the market estimates and forecasts
    • 1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
    • 1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Analytical Testing Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Innovation
      • 3.3.1.2. Regulation safety and quality
      • 3.3.1.3. End-users volume
      • 3.3.1.4. Pricing
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Data insecurity
      • 3.3.2.2. Third party performance
    • 3.3.3. Industry Challenges
  • 3.4. Pharmaceutical Analytical Testing Outsourcing: Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier Power
      • 3.4.1.2. Buyer Power
      • 3.4.1.3. Substitution Threat
      • 3.4.1.4. Threat from new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political Landscape
      • 3.4.2.2. Environmental Landscape
      • 3.4.2.3. Social Landscape
      • 3.4.2.4. Technology Landscape
      • 3.4.2.5. Legal Landscape
    • 3.4.3. Major Deals & Strategic Alliances Analysis

Chapter 4. Pharmaceutical Analytical Testing Outsourcing Market: Segment Analysis, by Service, 2016 - 2027 (USD Million)

  • 4.1. Segment Dashboard
  • 4.2. Definitions & Scope
  • 4.3. Service Market Share Analysis, 2019 & 2027
  • 4.4. Global Pharmaceutical Analytical Testing Outsourcing Market, By Service, 2016 to 2027
  • 4.5. Market Size & Forecasts And Trend Analysis, 2016 to 2027 for the following
    • 4.5.1. Bioanalytical Testing
      • 4.5.1.1. Clinical
      • 4.5.1.2. Non Clinical
    • 4.5.2. Method Development & Validation
      • 4.5.2.1. Extractable & Leachable
      • 4.5.2.2. Impurity Method
      • 4.5.2.3. Technical Consulting
      • 4.5.2.4. Others
    • 4.5.3. Stability Testing
    • 4.5.4. Drug Substance
      • 4.5.4.1. Stability Indicating Method Validation
      • 4.5.4.2. Accelerated Stability Testing
      • 4.5.4.3. Photostability Testing
      • 4.5.4.4. Others
    • 4.5.5. Others

Chapter 5. Pharmaceutical Analytical Testing Outsourcing Market: Regional Market Analysis, by Service, 2016 - 2027 (USD Million)

  • 5.1. Regional Market Dashboard
  • 5.2. Regional Market Share Analysis, 2019 & 2027
  • 5.3. Market Size, Forecasts, And Trend Analysis, 2016 to 2027:
  • 5.4. North America
    • 5.4.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 5.4.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.4.3. U.S.
      • 5.4.3.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.4.4. Canada
      • 5.4.4.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
  • 5.5. Europe
    • 5.5.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 5.5.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.5.3. U.K.
      • 5.5.3.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.5.4. Germany
      • 5.5.4.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.5.5. France
      • 5.5.5.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.5.6. Italy
      • 5.5.6.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.5.7. Spain
      • 5.5.7.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.5.8. Russia
      • 5.5.8.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.5.9. Turkey
      • 5.5.9.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.5.10. Netherlands
      • 5.5.10.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.5.11. Switzerland
      • 5.5.11.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.5.12. Sweden
      • 5.5.12.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 5.6.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.6.3. China
      • 5.6.3.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.6.4. Japan
      • 5.6.4.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.6.5. India
      • 5.6.5.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.6.6. Australia
      • 5.6.6.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.6.7. South Korea
      • 5.6.7.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.6.8. Indonesia
      • 5.6.8.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.6.9. Malaysia
      • 5.6.9.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.6.10. Singapore
      • 5.6.10.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.6.11. Thailand
      • 5.6.11.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.6.12. Taiwan
      • 5.6.12.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.7.3. Mexico
      • 5.7.3.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.7.4. Argentina
      • 5.7.4.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.7.5. Colombia
      • 5.7.5.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.7.6. Chile
      • 5.7.6.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
  • 5.8. Middle East and Africa
    • 5.8.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 5.8.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.8.3. South Africa
      • 5.8.3.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.8.4. Saudi Arabia
      • 5.8.4.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.8.5. UAE
      • 5.8.5.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.8.6. Egypt
      • 5.8.6.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
    • 5.8.7. Israel
      • 5.8.7.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)

Chapter 6. Pharmaceutical Analytical Testing Outsourcing Market - Competitive Analysis

  • 6.1. Key companies profiled
    • 6.1.1. SGS SA
      • 6.1.1.1. Company overview
      • 6.1.1.2. Financial performance
      • 6.1.1.3. Product benchmarking
      • 6.1.1.4. Strategic initiatives
    • 6.1.2. Toxikon, Inc.
      • 6.1.2.1. Company overview
      • 6.1.2.2. Financial performance
      • 6.1.2.3. Product benchmarking
      • 6.1.2.4. Strategic initiatives
    • 6.1.3. Eurofins Scientific
      • 6.1.3.1. Company overview
      • 6.1.3.2. Financial performance
      • 6.1.3.3. Product benchmarking
      • 6.1.3.4. Strategic initiatives
    • 6.1.4. Pace Analytical Services, Inc.
      • 6.1.4.1. Company overview
      • 6.1.4.2. Financial performance
      • 6.1.4.3. Product benchmarking
      • 6.1.4.4. Strategic initiatives
    • 6.1.5. Intertek Group Plc
      • 6.1.5.1. Company overview
      • 6.1.5.2. Financial performance
      • 6.1.5.3. Product benchmarking
      • 6.1.5.4. Strategic initiatives
    • 6.1.6. Pharmaceutical Product Development, LLC.
      • 6.1.6.1. Company overview
      • 6.1.6.2. Financial performance
      • 6.1.6.3. Product benchmarking
      • 6.1.6.4. Strategic initiatives
    • 6.1.7. WuXi AppTec, Inc.
      • 6.1.7.1. Company overview
      • 6.1.7.2. Financial performance
      • 6.1.7.3. Product benchmarking
      • 6.1.7.4. Strategic initiatives
    • 6.1.8. Boston Analytical
      • 6.1.8.1. Company overview
      • 6.1.8.2. Financial performance
      • 6.1.8.3. Product benchmarking
      • 6.1.8.4. Strategic initiatives
    • 6.1.9. Boston Analytical
      • 6.1.9.1. Company overview
      • 6.1.9.2. Financial performance
      • 6.1.9.3. Product benchmarking
      • 6.1.9.4. Strategic initiatives
    • 6.1.10. Charles River Laboratories International, Inc.
      • 6.1.10.1. Company overview
      • 6.1.10.2. Financial performance
      • 6.1.10.3. Product benchmarking
      • 6.1.10.4. Strategic initiatives
    • 6.1.11. West Pharmaceutical Services Inc.
      • 6.1.11.1. Company overview
      • 6.1.11.2. Financial performance
      • 6.1.11.3. Product benchmarking
      • 6.1.11.4. Strategic initiatives